GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » Cash Conversion Cycle

NUTX (Nutex Health) Cash Conversion Cycle : 43.52 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nutex Health Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Nutex Health's Days Sales Outstanding for the three months ended in Dec. 2024 was 53.56.
Nutex Health's Days Inventory for the three months ended in Dec. 2024 was 2.01.
Nutex Health's Days Payable for the three months ended in Dec. 2024 was 12.05.
Therefore, Nutex Health's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2024 was 43.52.


Nutex Health Cash Conversion Cycle Historical Data

The historical data trend for Nutex Health's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutex Health Cash Conversion Cycle Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial 78.39 96.63 109.27 49.90 92.40

Nutex Health Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.22 52.70 42.85 47.97 43.52

Competitive Comparison of Nutex Health's Cash Conversion Cycle

For the Medical Care Facilities subindustry, Nutex Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Nutex Health's Cash Conversion Cycle falls into.


;
;

Nutex Health Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Nutex Health's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=113.63+4.01-25.24
=92.40

Nutex Health's Cash Conversion Cycle for the quarter that ended in Dec. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=53.56+2.01-12.05
=43.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutex Health  (NAS:NUTX) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Nutex Health Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Nutex Health's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutex Health Business Description

Traded in Other Exchanges
N/A
Address
6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Executives
Jon Christian Bates officer: Chief Financial Officer 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio officer: Chief Operating Officer 6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Thomas T. Vo director, officer: Chairman, CEO 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem director 700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery officer: Chief Legal Off. & Secretary 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters director 2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites director 3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc 10 percent owner 2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen officer: Chief Financial Officer 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion director C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel officer: Chief Medical Information Off 5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg officer: President of subsidiary 10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc 10 percent owner 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081